Queen's University - Utility Bar

QSpace at Queen's University >
Theses, Dissertations & Graduate Projects >
Queen's Theses & Dissertations >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1974/972

Title: The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells
Authors: Singh, Roopam

Files in This Item:

File Description SizeFormat
Roopam_Singh_200801_MSc.pdf697.71 kBAdobe PDFView/Open
Keywords: Benzene
c-Myb
Topoisomerase II
Benzoquinone
Issue Date: 2008
Series/Report no.: Canadian theses
Abstract: Exposure to benzene, a ubiquitous environmental pollutant, has been linked to leukemogenesis, although the mechanism of benzene initiated carcinogenesis remains unclear. It has been proposed that benzene can be bioactivated to toxic metabolites such as 1,4 benzoquinone (BQ), which can alter signalling pathways and affect chromosomal integrity. BQ has been shown to increase the activity of c-Myb, which is an important transcription factor involved in hematopoiesis, cell proliferation, and cell differentiation. The c-Myb protein also increases topoisomerase IIα (topo IIα) promoter activity specifically in cell lines with hematopoietic origin. Topo II is a critical nuclear enzyme that removes torsional strain by cleaving, untangling and religating double-stranded DNA. Since topo II mediates DNA strand breaks, aberrant topo II activity or increased protein levels may increase the formation of DNA strand breaks, leaving the cell susceptible to mutational events. I hypothesize that BQ increases c-Myb activity, which in turn increases topo IIα promoter activity resulting in increased DNA strand breaks. Using luciferase reporter assays in K-562 cells (human chronic myeloid leukemic cells) I confirmed that BQ exposure (25 and 37 µM) caused an increase in c-Myb activity after 24 hours. Contradictory to previous findings, overexpression of exogenous c-Myb or a polypeptide consisting of c-Myb’s DNA binding domain (DBD), which competitively inhibits the binding of endogenous c-Myb to DNA, did not affect topo IIα promoter activity. However, BQ exposure (37 µM for 24 hours) caused a significant increase in topo IIα promoter activity, which could be blocked by the overexpression of the DBD polypeptide. Western immunoblotting analysis did not show any significant increases in topo IIα protein levels in cells exposed to 37 µM BQ for 24 hours. Overall, this study suggests that BQ exposure increases topo IIα promoter activity through the c-Myb signalling pathway and furthers our understanding of BQ-mediated toxicity.
Description: Thesis (Master, Pharmacology & Toxicology) -- Queen's University, 2008-01-02 14:09:00.011
URI: http://hdl.handle.net/1974/972
Appears in Collections:Queen's Theses & Dissertations
Pharmacology & Toxicology Graduate Theses

Items in QSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  DSpace Software Copyright © 2002-2008  The DSpace Foundation - TOP